Symptomatic Care in Multiple System Atrophy: State of the Art-Reference-Cited by-同舟云学术

Symptomatic Care in Multiple System Atrophy: State of the Art

Published:2022-05-17 Issue:3 Volume:22 Page:433-446
ISSN:1473-4230
Container-title:The Cerebellum
language:en
Short-container-title:Cerebellum

Author:

Grossauer Anna,Sidoroff Victoria,Heim Beatrice,Seppi Klaus^ORCID

Abstract

Abstract Without any disease-modifying treatment strategy for multiple system atrophy (MSA), the therapeutic management of MSA patients focuses on a multidisciplinary strategy of symptom control. In the present review, we will focus on state of the art treatment in MSA and additionally give a short overview about ongoing randomized controlled trials in this field.

Funder

University of Innsbruck and Medical University of Innsbruck

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s12311-022-01411-6.pdf

Reference106 articles.

1. Fanciulli A, Stankovic I, Krismer F, Seppi K, Levin J, Wenning GK. Multiple system atrophy. Int Rev Neurobiol. 2019;149:137–92. https://doi.org/10.1016/bs.irn.2019.10.004.

2. Fanciulli A, Wenning GK. Multiple-system atrophy. N Engl J Med. 2015;372(3):249–63. https://doi.org/10.1056/NEJMra1311488.

3. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology. 1997;49(5):1284–8. https://doi.org/10.1212/wnl.49.5.1284.